NGI-1 (ML414) (Synonyms: N-linked Glycosylation Inhibitor 1) |
Catalog No.GC33055 |
NGI-1 (ML414) (ML414) es un potente inhibidor de la oligosacariltransferasa (OST), que se dirige directamente y bloquea la funciÓn de las subunidades catalÍticas de la OST STT3A y STT3B. NGI-1 (ML414) es un inhibidor permeable a las células y puede reducir eficazmente la infectividad del virus sin afectar la viabilidad celular.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 790702-57-7
Sample solution is provided at 25 µL, 10mM.
NGI-1 is a cell permeable inhibitor.
NGI-1 blocks EGFR N-linked glycosylation in lung adenocarcinoma cells as assessed. In controls EGFR is biotinylated, consistent with its plasma membrane expression, but in NGI-1 treated cells the EGFR is predominantly found in the non-biotinylated intracellular fraction suggesting a change in cellular localization[1].
[1]. Lopez-Sambrooks C, et al. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nat Chem Biol. 2016 Dec;12(12):1023-1030.
Average Rating: 5
(Based on Reviews and 7 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *